794 related articles for article (PubMed ID: 27133009)
1. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
2. Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients.
Hu J; Jiao X; Yang Z; Cui H; Guo H; Wu Y; Zhu L
J Obstet Gynaecol; 2017 Nov; 37(8):1065-1069. PubMed ID: 28631536
[TBL] [Abstract][Full Text] [Related]
3. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
4. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
Lu H; Li J; Wang L; Zhou H; Liu Y; Wang D; Lin Z
Med Sci Monit; 2016 Feb; 22():408-14. PubMed ID: 26852916
[TBL] [Abstract][Full Text] [Related]
5. Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
Matsuo K; Shimada M; Yamaguchi S; Kanao H; Nakanishi T; Saito T; Kamiura S; Iwata T; Mikami M; Sugiyama T
Int J Cancer; 2018 Mar; 142(5):1022-1032. PubMed ID: 28975603
[TBL] [Abstract][Full Text] [Related]
6. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
8. Ovarian metastasis in stage IB and II cervical adenocarcinoma.
Natsume N; Aoki Y; Kase H; Kashima K; Sugaya S; Tanaka K
Gynecol Oncol; 1999 Aug; 74(2):255-8. PubMed ID: 10419741
[TBL] [Abstract][Full Text] [Related]
9. Ovarian preservation in adenocarcinoma of the uterine cervix.
Zhou J; Chen Y; Zhang P; Lou H
J Ovarian Res; 2017 Jul; 10(1):48. PubMed ID: 28738842
[TBL] [Abstract][Full Text] [Related]
10. Independent risk factors for ovarian metastases in stage IA-IIB cervical carcinoma.
Zhou L; Sun CT; Lin L; Xie Y; Huang Y; Li Q; Liu X
Acta Obstet Gynecol Scand; 2019 Jan; 98(1):18-23. PubMed ID: 30129170
[TBL] [Abstract][Full Text] [Related]
11. Ovarian preservation in young patients with stage I cervical adenocarcinoma: a surveillance, epidemiology, and end results study.
Lyu J; Sun T; Tan X
Int J Gynecol Cancer; 2014 Oct; 24(8):1513-20. PubMed ID: 25188889
[TBL] [Abstract][Full Text] [Related]
12. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
[TBL] [Abstract][Full Text] [Related]
13. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
[TBL] [Abstract][Full Text] [Related]
14. Ovarian metastasis in carcinoma of the uterine cervix.
Shimada M; Kigawa J; Nishimura R; Yamaguchi S; Kuzuya K; Nakanishi T; Suzuki M; Kita T; Iwasaka T; Terakawa N
Gynecol Oncol; 2006 May; 101(2):234-7. PubMed ID: 16300819
[TBL] [Abstract][Full Text] [Related]
15. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.
Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2017 Jan; 129(1):139-151. PubMed ID: 27926642
[TBL] [Abstract][Full Text] [Related]
18. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
19. Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review.
Touhami O; Plante M
Gynecol Oncol; 2015 Feb; 136(2):384-8. PubMed ID: 25511157
[TBL] [Abstract][Full Text] [Related]
20. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
